Fenofibrate and Peripheral coldness - a phase IV clinical study of FDA data

Summary:

Peripheral coldness is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are male, 60+ old, also take Votrient, and have Diabetes.

The phase IV clinical study analyzes which people have Peripheral coldness when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Peripheral coldness?

Peripheral coldness is found to be associated with 1,082 drugs and 1,153 conditions by eHealthMe. Check the latest studies of Peripheral coldness.

On Jul, 26, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 20 people (0.05%) have Peripheral coldness.

Could Fenofibrate cause Peripheral coldness?

Among these 20 people:

What is the gender of people who have Peripheral coldness when taking Fenofibrate? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Peripheral coldness when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Peripheral coldness? *

Abdominal Discomfort: 6 people, 30.00%
Neuropathy Peripheral (surface nerve damage): 6 people, 30.00%
Pain In Extremity: 5 people, 25.00%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 5 people, 25.00%
Flatulence (flatus expelled through the anus): 5 people, 25.00%
Fatigue (feeling of tiredness): 4 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 20.00%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 4 people, 20.00%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 20.00%
Pain: 4 people, 20.00%

What are the existing conditions these people have? *

Diabetes: 6 people, 30.00%
Colon Cancer: 4 people, 20.00%
Renal Cell Carcinoma (a kidney cancer): 4 people, 20.00%
Osteoporosis (bones weak and more likely to break): 2 people, 10.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 5.00%
Diplegia (paralysis of corresponding parts on both sides of the body): 1 person, 5.00%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 1 person, 5.00%
Depression: 1 person, 5.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.00%
Constipation: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Peripheral coldness?

- Check whether Peripheral coldness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,456 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Peripheral coldness:

Peripheral coldness (1,082 drugs)

Browse all the conditions that are associated with Peripheral coldness:

Peripheral coldness (1,153 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.